| HK2 positive | HK2 negative | P value |
---|---|---|---|
Age | |||
  ≤ 50 year | 23 | 19 | 0.062 |
  > 50 year | 43 | 70 |  |
Gender | Â | Â | 0.360 |
 Male | 51 | 74 |  |
 Female | 15 | 15 |  |
Hepatitis virus infection | Â | Â | 0.594 |
 HBV | 57 | 78 |  |
 HCV | 3 | 3 |  |
 HBV + HCV | 0 | 2 |  |
 None | 6 | 6 |  |
AFP level | Â | Â | 0.054 |
  ≤ 20ug/L | 26 | 49 |  |
  > 20ug/L | 40 | 40 |  |
Tumor number | Â | Â | 0.121 |
 Solitary | 65 | 83 |  |
 Multiple | 1 | 6 |  |
Tumor size | Â | Â | 0.001 |
  ≤ 5 cm | 40 | 75 |  |
  > 5 cm | 26 | 14 |  |
TNM stage | Â | Â | 0.015 |
 I | 26 | 30 |  |
 II | 18 | 45 |  |
 III | 16 | 10 |  |
 IV | 6 | 4 |  |
Differentiation | Â | Â | 0.145 |
 Well | 19 | 31 |  |
 Moderate | 28 | 44 |  |
 Poor | 19 | 14 |  |
Post operation treatment | Â | Â | 0.630 |
 None | 44 | 56 |  |
 TACE | 22 | 33 |  |